220 related articles for article (PubMed ID: 29710317)
1. Association of Substance Use Disorders With Conversion From Schizotypal Disorder to Schizophrenia.
Hjorthøj C; Albert N; Nordentoft M
JAMA Psychiatry; 2018 Jul; 75(7):733-739. PubMed ID: 29710317
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.
Grant BF; Saha TD; Ruan WJ; Goldstein RB; Chou SP; Jung J; Zhang H; Smith SM; Pickering RP; Huang B; Hasin DS
JAMA Psychiatry; 2016 Jan; 73(1):39-47. PubMed ID: 26580136
[TBL] [Abstract][Full Text] [Related]
3. Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder.
Østergaard MLD; Nordentoft M; Hjorthøj C
Addiction; 2017 Jul; 112(7):1250-1259. PubMed ID: 28192643
[TBL] [Abstract][Full Text] [Related]
4. Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
Nielsen SM; Toftdahl NG; Nordentoft M; Hjorthøj C
Psychol Med; 2017 Jul; 47(9):1668-1677. PubMed ID: 28166863
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia is associated with increased risk of subsequent substance abuse diagnosis: A nation-wide population-based register study.
Petersen SM; Toftdahl NG; Nordentoft M; Hjorthøj C
Addiction; 2019 Dec; 114(12):2217-2226. PubMed ID: 31301685
[TBL] [Abstract][Full Text] [Related]
6. Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder.
Jefsen OH; Erlangsen A; Nordentoft M; Hjorthøj C
JAMA Psychiatry; 2023 Aug; 80(8):803-810. PubMed ID: 37223912
[TBL] [Abstract][Full Text] [Related]
7. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.
Starzer MSK; Nordentoft M; Hjorthøj C
Am J Psychiatry; 2018 Apr; 175(4):343-350. PubMed ID: 29179576
[TBL] [Abstract][Full Text] [Related]
8. Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Davis GP; Compton MT; Wang S; Levin FR; Blanco C
Schizophr Res; 2013 Dec; 151(1-3):197-202. PubMed ID: 24200416
[TBL] [Abstract][Full Text] [Related]
9. Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls.
Olesen JA; Posselt CM; Poulsen CH; Nordentoft M; Hjorthøj C
Psychol Med; 2020 Feb; 50(3):499-506. PubMed ID: 30880659
[TBL] [Abstract][Full Text] [Related]
10. Opioid abuse and hospitalization rates in patients with schizophrenia.
Kivimies K; Repo-Tiihonen E; Kautiainen H; Maaranen P; Muhonen LH; Heikkinen M; Tiihonen J
Nord J Psychiatry; 2016; 70(2):128-32. PubMed ID: 26313367
[TBL] [Abstract][Full Text] [Related]
11. Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood.
Anglin DM; Corcoran CM; Brown AS; Chen H; Lighty Q; Brook JS; Cohen PR
Schizophr Res; 2012 May; 137(1-3):45-9. PubMed ID: 22325079
[TBL] [Abstract][Full Text] [Related]
12. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.
Blanco C; Hasin DS; Wall MM; Flórez-Salamanca L; Hoertel N; Wang S; Kerridge BT; Olfson M
JAMA Psychiatry; 2016 Apr; 73(4):388-95. PubMed ID: 26886046
[TBL] [Abstract][Full Text] [Related]
13. Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong, 2000-10: a nested case-control study.
Chai Y; Luo H; Wong GHY; Tang JYM; Lam TC; Wong ICK; Yip PSF
Lancet Psychiatry; 2020 Feb; 7(2):135-147. PubMed ID: 31974072
[TBL] [Abstract][Full Text] [Related]
14. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
[TBL] [Abstract][Full Text] [Related]
15. A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents.
Köhler-Forsberg O; Petersen L; Gasse C; Mortensen PB; Dalsgaard S; Yolken RH; Mors O; Benros ME
JAMA Psychiatry; 2019 Mar; 76(3):271-279. PubMed ID: 30516814
[TBL] [Abstract][Full Text] [Related]
16. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
[TBL] [Abstract][Full Text] [Related]
17. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study.
Hjorthøj C; Østergaard ML; Benros ME; Toftdahl NG; Erlangsen A; Andersen JT; Nordentoft M
Lancet Psychiatry; 2015 Sep; 2(9):801-8. PubMed ID: 26277044
[TBL] [Abstract][Full Text] [Related]
18. Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence.
Hines LA; Freeman TP; Gage SH; Zammit S; Hickman M; Cannon M; Munafo M; MacLeod J; Heron J
JAMA Psychiatry; 2020 Oct; 77(10):1044-1051. PubMed ID: 32459328
[TBL] [Abstract][Full Text] [Related]
19. Absolute risk of suicide after first hospital contact in mental disorder.
Nordentoft M; Mortensen PB; Pedersen CB
Arch Gen Psychiatry; 2011 Oct; 68(10):1058-64. PubMed ID: 21969462
[TBL] [Abstract][Full Text] [Related]
20. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
